MRNA MODERNA INC revenue, earnings and financials
For the quarter ended June 30, 2026, MODERNA INC reported revenue of $145M (up 2.1% from a year earlier), net income of −$782M and diluted EPS of −$1.97; over the last four quarters revenue was $2.23B and net income −$3.15B; for the fiscal year ended December 2025 revenue was $1.94B, down 39.9% on the year before.
MRNA annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $1.94B, gross profit n/a, operating income −$3.07B, net income −$2.82B (margin -145.2%), EPS −$7.26
- Fiscal year ended Dec 2024: revenue $3.24B, gross profit n/a, operating income −$3.95B, net income −$3.56B (margin -110.0%), EPS −$9.28
- Fiscal year ended Dec 2023: revenue $6.85B, gross profit n/a, operating income −$4.24B, net income −$4.71B (margin -68.8%), EPS −$12.33
- Fiscal year ended Dec 2022: revenue $19.3B, gross profit n/a, operating income $9.42B, net income $8.36B (margin 43.4%), EPS $20.12
- Fiscal year ended Dec 2021: revenue $18.5B, gross profit n/a, operating income $13.3B, net income $12.2B (margin 66.1%), EPS $28.29
MRNA quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $145M (up 2.1% year over year), net income −$782M, EPS −$1.97
- Quarter ended Mar 31, 2026: revenue $389M (up 260.2% year over year), net income −$1.34B, EPS −$3.40
- Quarter ended Dec 31, 2025 (from the annual report): revenue $678M (down 29.8% year over year), net income −$826M, EPS −$2.10
- Quarter ended Sep 30, 2025: revenue $1.02B (down 45.4% year over year), net income −$200M, EPS −$0.51
- Quarter ended Jun 30, 2025: revenue $142M (down 41.1% year over year), net income −$825M, EPS −$2.13
- Quarter ended Mar 31, 2025: revenue $108M (down 35.3% year over year), net income −$971M, EPS −$2.52
- Quarter ended Dec 31, 2024 (from the annual report): revenue $966M (down 65.6% year over year), net income −$1.12B, EPS −$2.91
- Quarter ended Sep 30, 2024: revenue $1.86B (up 1.7% year over year), net income $13.0M, EPS $0.03
- Quarter ended Jun 30, 2024: revenue $241M (down 29.9% year over year), net income −$1.28B, EPS −$3.33
- Quarter ended Mar 31, 2024: revenue $167M (down 91.0% year over year), net income −$1.18B, EPS −$3.07
- Quarter ended Dec 31, 2023 (from the annual report): revenue $2.81B (down 44.7% year over year), net income $217M, EPS $0.63
- Quarter ended Sep 30, 2023: revenue $1.83B (down 45.6% year over year), net income −$3.63B, EPS −$9.53
- Quarter ended Jun 30, 2023: revenue $344M (down 92.8% year over year), net income −$1.38B, EPS −$3.62
- Quarter ended Mar 31, 2023: revenue $1.86B (down 69.3% year over year), net income $79.0M, EPS $0.19
- Quarter ended Dec 31, 2022 (from the annual report): revenue $5.08B (down 29.5% year over year), net income $1.47B, EPS $3.77
- Quarter ended Sep 30, 2022: revenue $3.36B (down 32.3% year over year), net income $1.04B, EPS $2.53
- Quarter ended Jun 30, 2022: revenue $4.75B (up 9.1% year over year), net income $2.20B, EPS $5.24
- Quarter ended Mar 31, 2022: revenue $6.07B (up 213.2% year over year), net income $3.66B, EPS $8.58
- Quarter ended Dec 31, 2021 (from the annual report): revenue $7.21B, net income $4.87B, EPS $11.29
- Quarter ended Sep 30, 2021: revenue $4.97B, net income $3.33B, EPS $7.70
MRNA cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$1.87B, share buybacks $2.00M
- Fiscal year ended Dec 2024: operating cash flow −$3.00B, share buybacks $0
- Fiscal year ended Dec 2023: operating cash flow −$3.12B, share buybacks $1.15B
- Fiscal year ended Dec 2022: operating cash flow $4.98B, share buybacks $3.33B
- Fiscal year ended Dec 2021: operating cash flow $13.6B, share buybacks $857M
MRNA balance sheet
- Jun 30, 2026: cash $1.72B, total assets $11.0B, total liabilities $4.20B, shareholders' equity $6.76B, long-term debt $591M
- Mar 31, 2026: cash $1.91B, total assets $11.5B, total liabilities $4.08B, shareholders' equity $7.41B, long-term debt $590M
- Dec 31, 2025: cash $2.60B, total assets $12.3B, total liabilities $3.69B, shareholders' equity $8.65B, long-term debt $590M
- Sep 30, 2025: cash $1.13B, total assets $12.1B, total liabilities $2.81B, shareholders' equity $9.33B
- Jun 30, 2025: cash $1.28B, total assets $12.0B, total liabilities $2.61B, shareholders' equity $9.40B
- Mar 31, 2025: cash $1.62B, total assets $12.7B, total liabilities $2.64B, shareholders' equity $10.1B
- Dec 31, 2024: cash $1.93B, total assets $14.1B, total liabilities $3.24B, shareholders' equity $10.9B, long-term debt $0
- Sep 30, 2024: cash $1.64B, total assets $15.8B, total liabilities $3.88B, shareholders' equity $11.9B
What is MRNA's revenue?
MODERNA INC reported $2.23B of revenue over its last four quarters, through June 30, 2026.
Is MRNA profitable?
No. MODERNA INC lost $3.15B over the last four quarters.
What is MRNA's EPS?
Diluted earnings per share over the last four quarters were −$7.98; −$1.97 in the latest quarter.